
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma
Keywords: کارسینوم سلول کلیوی یا RCC ; Bisphosphonates; Bone metastases; Outcome; Renal cell carcinoma; Sunitinib;